Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
In December 2025, Castle Biosciences reported Nature Communications data from the largest prospective, multicenter uveal melanoma study showing that combining its DecisionDx-UM test with PRAME gene ...
Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be built upon or applied. More may rest on the tools researchers use than previously ...
Next Gen Diagnostics (NGD) today announced that January 1 the Company will spin off its Infection Prevention division into an independent company, NGD Infection Prevention, focused on the ...
Research into how a father’s choices — such as diet, exercise, stress, nicotine use — may transfer traits to his children has ...
Looking back, the unifying insight across these experiences is simple: Lasting impact comes from ventures that genuinely ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
A father’s exposure to microplastics can alter sperm RNA in ways that increase metabolic disease risk in his daughters.
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Taking this class absolutely transformed what I thought about science and how I thought about myself as a student,” Nellie ...
Structural engineers collaborate closely with façade, HVAC and plumbing specialists to synchronise designs that reduce rework ...
Inc42 and Shadowfax jointly kicked off the first edition of D2CX Converge in Hyderabad, bringing together over 50 early stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results